They Thought These Drugs Were About Food. They Are About Something Much Bigger.

A patient sat across from me and said something I have not stopped thinking about.

She had been on a GLP-1 medication for about six weeks. Weight loss was happening, but that was not what she wanted to talk about. She wanted to talk about the silence.

“I did not realize how loud it was,” she said, “until it stopped.”

She was not talking about noise in the room. She was talking about the noise in her head. The constant, low-grade mental chatter about food — what she had eaten, what she wanted to eat, what she should not eat, what she would eat later. The background hum she had lived with so long, she had stopped noticing it was there.

And then, almost overnight, it was gone.

I know what it looks like when a patient describes relief. This was something different. This was someone describing the sudden absence of something they had never been able to name.

She called it food noise.

And the moment she said it, something clicked for me — because I had been hearing versions of that same story from other patients. Not just about food. About alcohol. About scrolling. About spending. About the pull toward behaviors they had been fighting, with varying degrees of success, for most of their adult lives.

The drug had not just quieted her appetite.

It had turned down the volume on something much larger.

What We Are Actually Talking About

Here is the thing about food noise that most coverage gets wrong: food is almost beside the point.

Food noise is not about hunger. Hunger is physical — it rises, you eat, it resolves. Food noise is cognitive. It is the mental chatter that runs independent of physical need, the thoughts that surface again and again without invitation, the low-grade negotiation that never fully stops.

And it is not unique to food.

The same phenomenon shows up in people who cannot stop thinking about their next drink. In people who describe the urge to gamble as a presence in the room. In people with ADHD who bounce from tab to tab, not because they want to, but because something in their brain keeps pulling them toward the next thing, and the next, and the next.

Different behaviors. Identical language.

A noise. A pull. A hum that will not stop.

What if these people are all describing the same thing — just through different entry points?

I think they are. And I think it has a name: reward noise.

The System Behind the Pull

Your brain has a reward system. You probably know this in the abstract, but it is worth understanding what it actually does.

The dopamine circuitry — centered in areas like the ventral tegmental area, the nucleus accumbens, and the prefrontal cortex — is your brain's relevance detector. It does not just make things feel good. It decides what feels important. What is worth your attention? What is worth pursuing?

And it is not unique to food.

The same phenomenon shows up in people who cannot stop thinking about their next drink. In people who describe the urge to gamble as a presence in the room. In people with ADHD who bounce from tab to tab, not because they want to, but because something in their brain keeps pulling them toward the next thing, and the next, and the next.

Different behaviors. Identical language.

A noise. A pull. A hum that will not stop.

What if these people are all describing the same thing — just through different entry points?

I think they are. And I think it has a name: reward noise.

The System Behind the Pull

Your brain has a reward system. You probably know this in the abstract, but it is worth understanding what it actually does.

The dopamine circuitry — centered in areas like the ventral tegmental area, the nucleus accumbens, and the prefrontal cortex — is your brain's relevance detector. It does not just make things feel good. It decides what feels important. What is worth your attention? What is worth pursuing?

When this system is calibrated well, it functions like a compass. It points toward things that genuinely matter — meaningful work, real connection, nourishment — and lets lower-value stimuli remain background noise. But when it is miscalibrated, those inputs flip. Low-value stimuli start feeling urgent. The detector becomes a siren.

This is where GLP-1 medications enter the picture — and where things get interesting.

GLP-1 stands for glucagon-like peptide 1. It is a hormone produced naturally in the gut after eating. Medications like semaglutide — sold as Ozempic and Wegovy — and tirzepatide — Mounjaro and Zepbound — mimic this hormone. They were developed as metabolic treatments: regulate blood sugar, suppress appetite, reduce food intake via gut signaling. That was the intended mechanism.

But GLP-1 receptors are not only in the gut.

They are in the brainstem. In the hypothalamus. In the nucleus accumbens — the brain's reward hub. In areas directly involved in motivation, salience, and the felt urgency of wanting. This was not something researchers prioritized when these drugs were developed as metabolic treatments. It is becoming impossible to ignore now.

The working hypothesis — still being assembled — is that GLP-1 medications may reduce the reward salience of highly reinforcing stimuli. Not by blocking dopamine. Not by altering mood. But by adjusting the signal-to-noise ratio of the reward system itself. The pull becomes quieter. The demand becomes more of an option.

Food. Alcohol. Compulsive behavior. Things that patient after patient is spontaneously reporting they can — for the first time in memory — simply choose not to pursue.

This is not the drug working as intended. This is a side effect that happens to be illuminating something fundamental about the architecture of craving.

What This Has to Do with ADHD

This is where I want to slow down, because this part matters enormously and almost no one is discussing it.

ADHD is described as a disorder of attention. But that framing obscures what is actually happening neurologically.

ADHD is, at its core, a disorder of reward processing.

The dopamine signaling differences in ADHD do not just make it hard to focus. They alter the entire experience of motivation and desire. Future rewards feel less compelling. Immediate rewards feel overwhelming. The brain's ability to say wait — to let a future good compete meaningfully with a present pull — is compromised not by laziness or lack of willpower, but by the literal mechanics of how dopamine signals are processed.

In other words, the reward system is louder.

This is why ADHD co-occurs at striking rates with binge eating, substance use disorders, compulsive spending, and impulsive behavior across the board. It is not a coincidence. It is not comorbidity in the random sense. It is the same underlying biology expressing itself across multiple domains simultaneously.

When my ADHD patients describe the exhaustion of constantly fighting their own impulses — the way they have to work twice as hard to do what others seem to do automatically — they are describing the experience of navigating a world designed for people whose reward systems run at a different volume.

If GLP-1 medications genuinely modulate reward salience, they may be targeting the same substrate. This neural circuitry governs craving, impulsivity, and behavioral control not just in obesity, but across the full range of reward-driven conditions.

The implications of that are profound.

The Waiting Room Nobody Designed

Medicine has a compartmentalization problem.

Obesity medicine has one language for food noise. Addiction psychiatry has a different language for cravings. ADHD research has yet another language for reward dysregulation. Each field developed in relative isolation, treating its patients in separate systems, rarely comparing notes.

But patients do not fit neatly into categories.

They present with binge eating and impulsive spending. With substance use and distractibility. With a lifetime of feeling pulled toward things they do not entirely want, unable to explain why the pull is so much stronger for them than it seems to be for everyone else.

What they may share — what may tie all of these experiences together — is a reward system running at a volume that most people do not have to manage.

It is neuroscience.

Why This Moment Matters

I want to be honest about what we know and what we do not.

The evidence here is early. Much of it is observational — patients reporting changes that were not the intended target of treatment, researchers noticing patterns across clinical populations. The mechanistic picture is still being assembled. We do not yet have the clinical trials that would let us speak with certainty.

But in medicine, patients often name things before science can explain them.

Food noise was a patient-generated term. No researcher coined it. People who lived it found the words for it, and only afterward did we begin to understand the biology underneath.

What is happening now — patients across clinical contexts describing the same unexpected quieting, the same loosened grip, the same lowered volume — feels like another moment of that kind.

Something is being named.

Why do some people's brains demand, at full volume, things that other people can take or leave?

Why does the pull feel like a command for some people and a suggestion for others?

Why does wanting feel, for some people, more like being wanted by something?

We may be closer to answering those questions than we have ever been.

And the answer will not just change how we treat obesity — it will change how we understand addiction, impulsivity, ADHD, and the fundamental biology of human desire.

If this resonated, I write about the neuroscience of mental health, ADHD, and the biology of behavior. Share it with someone who needs the language.

Related Reading